Journal of Clinical and Aesthetic Dermatology

APR 2018

An evidence-based, peer-reviewed journal for practicing clinicians in the field of dermatology

Issue link: https://jcadonline.epubxp.com/i/959274

Contents of this Issue

Navigation

Page 53 of 61

JCAD JOURNAL OF CLINICAL AND AESTHETIC DERMATOLOGY April 2018 • Volume 11 • Number 4 54 AADA RESPONDS TO UNITED STATES PREVENTIVE SERVICES TASK FORCE (USPSTF) RECOMMENDATION ON SKIN C ANCER PREVENTION COUNSELING On March 20, 2018, Suzanne M. Olbricht, MD, FAAD, president of the AADA, released a statement commending the USPSTF for addressing the importance of skin cancer prevention counseling, particularly in the youngest, most vulnerable patients. However, Olbricht made a point to stress the importance of skin cancer prevention for people of all ages and skin types, not just those with fair skin six months to24 years of age. * For more information: https:// www.aad.org/media/news-releases/ skin-cancer-prevention-counseling DERMATOLOGY SC ALE VALIDATES QUALIT Y OF LIFE A recently published study from researchers at Boston University School of Medicine that compared the widely used Dermatology Life Quality Index (DLQI) and the non-validated Skin Discoloration Impact Evaluation Questionnaire (SDIEQ) concluded that both scales were similarly effective in measuring quality of life; however, SDIEQ was found to be simpler to use and less time consuming. * For more information: https:// medicalxpress.com/news/2018-03-dermatol- ogy-scale-validates-quality-life.html BOTANIC AL DERMATOLOGY BRAND K AMEDIS FORMS UNITED STATES MEDIC AL ADVISORY BOARD On March 19, 2018, Kamedis™, a provider of advanced botanical solutions for chronic skin disorders, announced the formation of a US medical advisory board to support the Israeli-based company's launch in the US. Board members will supply scientific and medical expertise as well as strategic advice to assist Kamedis in building its US market presence. * For more information: https://www. prnewswire.com/news-releases/botanical-der- matology-brand-kamedis-forms-us-medi- cal-advisory-board-300615931.html NETHERLANDS BIOTECH ESCALIER GETS $19M FOR PIVOTAL DERMATOLOGY TESTS In dermatology biotechnology news, European venture capitalist firms Forbion, New Science Ventures, and BioGeneration Ventures have helped bump up a $19 million series B round for Escalier Biosciences and its dermatologic and autoimmune targets. Escalier plans on introducing their new therapies in mid-2018, which target the increased production of pro-inflammatory cytokines that have been linked to the pathophysiology of psoriasis. * For more information: https://www. fiercebiotech.com/biotech/netherlands-bio- tech-escalier-gets-19m-for-pivotal-dermato- logy-tests "PATTING," THE LATEST JAPANESE SKINCARE TREND, GAINS ATTENTION FROM THE UNITED STATES MEDIA An article published on March 20, 2018, in Allure magazine brought attention to the practice of gently patting skincare products into the skin, a popular habit among Japanese women, in favor of rubbing. The patting process was endorsed in the article by New York dermatologist Arash Akhavan, MD. Dr. Akhavan explains that patting helps to avoid inflammation and irritation potentially caused by rubbing the skin. * For more information: https:// www.allure.com/story/patting-japa- nese-skin-care-technique FINANCIAL SIDE EFFEC TS FROM A PRESCRIPTION FOR TOENAIL FUNGUS Reporters from NPR have highlighted the need for diligence in effective physician- patient communication when they profiled a patient who was surprised to find her health reimbursement account had been depleted after her dermatologist prescribed a topical antifungal medication that cost her nearly $1,500 for a month's supply. With proper counseling from physicians, the article notes, missteps in care such as this can be avoided. * For more information: https://www.npr.org/sections/health- shots/2018/03/16/594031602/financial-side- effects-from-a-prescription-for-toenail-fungus NIAMINACIDE ATTRAC TS ATTENTION FROM CONSUMER MEDIA An article published online in Women's Health on March 20, 2018, discussed the benefits of using skincare products containing the powerful anti-inflammatory ingredient, niaminacide, which the authors say is beneficial for "red, irritated or blotchy" skin. * For more information: https://www. womenshealthmag.com/beauty/a19472917/ what-is-niacinamide/ NEW MEXICO PASSES STEP THERAPY REFORM LEGISLATION The National Psoriasis Foundation along with multiple patient advocacy organizations released a statement in support of New Mexico NEWS & TRENDS Exploring the internet for the latest reports on research, products, and trends in dermatology J Clin Aesthet Dermatol. 2018;11(4):54–56 In the digital edition, click * to read the full article online.

Articles in this issue

Links on this page

Archives of this issue

view archives of Journal of Clinical and Aesthetic Dermatology - APR 2018